2000
DOI: 10.1016/s0360-3016(99)00485-x
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
20
1
1

Year Published

2002
2002
2019
2019

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(24 citation statements)
references
References 13 publications
2
20
1
1
Order By: Relevance
“…For superficial esophageal cancer (T1N0M0), RT alone with or without intraluminal brachytherapy (IBT) is also as effective as concurrent CRT [11][12][13][14]. Recently, a phase II clinical trial of concurrent CRT for superficial esophageal cancer with submucosal invasion has been reported by the Japan Clinical Oncology Group (JCOG) [15].…”
Section: Introductionmentioning
confidence: 99%
“…For superficial esophageal cancer (T1N0M0), RT alone with or without intraluminal brachytherapy (IBT) is also as effective as concurrent CRT [11][12][13][14]. Recently, a phase II clinical trial of concurrent CRT for superficial esophageal cancer with submucosal invasion has been reported by the Japan Clinical Oncology Group (JCOG) [15].…”
Section: Introductionmentioning
confidence: 99%
“…In a multicenter analysis of external radiation therapy for superficial carcinoma. Nemoto et al [16] reported that 5-year local control rates were 100% for mucosal carcinoma and 70% for submucosal carcinoma. Yamada et al [20] reported a local recurrence rate of 16 to 34% after radiotherapy for esophageal superficial carcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…There have been similar reports of treatment with radiotherapy alone. Okawa et al reported a 7.2% 5-year survival rate for the advanced type of esophageal cancer treated with ERT alone (10), while they recently reported a 45% 5-year survival rate for the super cial type of esophageal cancer treated by ERT alone (11). In advanced type cancer, there was a difference in CR Table 5 The relationship between local control and dose of ILBT rates among types (Table 3).…”
Section: Discussionmentioning
confidence: 99%